MedTrace Logo

Psychosis and Affective Research Domains and Intermediate Phenotypes

NCT02218853 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 113

Last updated 2019-09-19

No results posted yet for this study

Summary

The objective of this multi-site research collaboration is to test the manifestation and distribution of biological markers for psychosis and affect dimensions across the schizophrenia/bipolar (SZ-BD) diagnostic boundary, and to examine heritability and genetic associations for these biological markers.

Conditions

  • Bipolar I Disorder, Unspecified, With Psychotic Features
  • Bipolar I Disorder, Unspecified, Without Psychotic Features

Sponsors & Collaborators

  • Beth Israel Deaconess Medical Center

    collaborator OTHER

  • Hartford Hospital

    collaborator OTHER

  • University of Georgia

    collaborator OTHER

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • University of Texas Southwestern Medical Center

    lead OTHER

Principal Investigators

  • Carol A Tamminga, M.D. · UT Southwestern Medical Center

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2017-06-30
Completion
2017-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02218853 on ClinicalTrials.gov